Frequently Asked Questions
The global frozen shoulder market is projected to grow at a CAGR of 10% during the forecast period of 2022-2029.
Factors such as the elderly population and rising incidence of shoulder injuries are the major drivers for the global frozen shoulder market.
The major players operating in the Frozen Shoulder Market are GlaxoSmithKline plc (U.S.), Contract Pharmacal Corp (U.S.), Amneal Pharmaceuticals, Inc. (U.S.), Vintage Labs (India), Dr. Reddy's Laboratories Ltd (India), Marksans Pharma (India), Sun Pharmaceutical Industries Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (U.S.), Perrigo Company plc (Ireland), Johnson & Johnson Private Limited (U.S.).
The major countries covered in the Frozen Shoulder Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
